BioCentury
ARTICLE | Clinical News

Angiomax bivalirudin small molecule direct thrombin inhibitor regulatory update

August 11, 2003 7:00 AM UTC

MDCO submitted an MAA and an sNDA to the EMEA and FDA, respectively, to expand the label for its AngioMax bivalirudin to treat patients undergoing percutaneous coronary intervention (PCI) with heparin...